Key points are not available for this paper at this time.
In adults with influenza A or B virus infections, direct administration of a selective neuraminidase inhibitor, zanamivir, to the respiratory tract is safe and reduces symptoms if begun early.
Hayden et al. (Thu,) studied this question.